• Disease areas
  • Products
  • Sustainable business
  • Partnering & innovation
  • Careers
  • About us
  • Patient help
  • Healthcare professionals
  • Investors
  • News & media
  • Contact us

A woman showing her biceps after a successful workout

Man living with Hypoglycaemia leaving his home on a positive note

Latest news

{{'Fri, 05 Dec 2025 18:05:00 -0500' | dateFormatUsFilter}}

Novo Nordisk warns consumers about counterfeit Ozempic® (semaglutide) injection 1 mg in the US

Read more

{{'Wed, 26 Nov 2025 08:00:00 -0500' | dateFormatUsFilter}}

Novo Nordisk files for FDA approval of a higher dose of Wegovy® injection 7.2 mg

Read more

{{'Mon, 17 Nov 2025 07:45:00 -0500' | dateFormatUsFilter}}

Novo Nordisk launches introductory self-pay offer for Wegovy® and Ozempic® for $199 per month

Read more

News archive

Latest on compounded and counterfeit products and other important information about semaglutide.

Visit semaglutide.com

Careers


Your place is here. Discover your career at Novo Nordisk.

NOVO NORDISK USA

800 Scudders Mill Road
Plainsboro, NJ 08536
Tel: 1-609-987-5800

 

Transparency in Employee Health Coverage:

Aetna
United Healthcare

Helpful links

  • Contact us
  • Copyright
  • Report a side effect or product complaint

Follow us

  • Facebook
  • X (Twitter)
  • Instagram

Other offices

Select location
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Privacy Policy
Consumer Health Data Privacy Notice
Cookie Policy
Privacy Request

change